NASH Core Curriculum: Imaging and Laboratory Tests for Diagnosis and Risk Stratification

Learn the best tools and approaches to identify NAFLD and to rule in or rule out NASH fibrosis.
Wing-Kin Syn, MBChB, PhD, FACP, FRCP
Format: Microsoft PowerPoint (.ppt)
File Size: 1.57 MB
Released: April 27, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Gilead Sciences
Novo Nordisk Inc.

Related Content

Expert advice on current NAFLD/NASH treatments: Mediterranean diet, vitamin E, pioglitazone, GLP-RAs, eg semaglutide. From Clinical Care Options (CCO)

Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: June 2, 2021 Expired: June 1, 2022

Unlocked slides from Giada Sebastiani, MD and CCO: Role of diet, exercise, and current treatments for NASH

Giada Sebastiani, MD Released: June 2, 2021

Video from CCO: best practice for identifying NAFLD and risk of progression to NASH. Biomarkers and imaging to rule in or out significant/advanced hepatic fibrosis

Wing-Kin Syn, MBChB, PhD, FACP, FRCP Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: April 27, 2021 Expired: April 26, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue